United States Biotechnology & Medical Research

Pasithea Therapeutics Corp (KTTA)

Track

Pasithea Therapeutics Corp recorded two buy transactions totaling $106,000 over the past ninety days, all executed by Coastlands Capital LP. This activity follows a recent positive earnings report. Despite these acquisitions, the stock price has declined 35.9% during this period, currently trading near its yearly low.
Ticker: KTTA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Pasithea Therapeutics Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 17 Jun 2026
Value US$3,286,170.81 | Price 86.67 | Shares 86,561 (+0.9%)
Buy 17 Jun 2026
Value US$191,285.59 | Price 465.97 | Shares 48,724 (-35.3%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-22 2026-06-17 B Purchase
Coastlands Capital LP
Large shareholder
86,561 +0.9%
86.67
US$3,286,171 		86,561 +0.9% 86.67 US$3,286,171
2026-06-22 2026-06-17 B Purchase
Coastlands Capital LP
Large shareholder
48,724 -35.3%
465.97
US$191,286 		48,724 -35.3% 465.97 US$191,286
2025-12-01 2025-11-28 B Purchase
2.3
STEINMAN LAWRENCE
Non-Executive Director
79,301 -10.6%
136.59
US$4,796,794 		79,301 -10.6% 136.59 US$4,796,794
2025-12-01 2025-11-28 B Purchase
2.3
Marques Tiago

Chief Executive Officer

Executive Director
33,333 +83.3%
0.75
US$25,000 		33,333 +83.3% 0.75 US$25,000
2025-12-01 2025-11-28 B Purchase
Dumesnil Simon
Non-Executive Director
33,333 +1333.3%
0.75
US$25,000 		33,333 +1333.3% 0.75 US$25,000
2025-05-14 2025-05-12 PrS Proposed sale
2.3
Tiago Reis Marques

Officer, Director

Executive Director
960
0.83
US$798 		960 0.83 US$798
2025-05-14 2025-05-12 S Sale
2.3
Marques Tiago

Chief Executive Officer

Executive Director
960 -2.3%
0.83
US$792 		960 -2.3% 0.83 US$792
2023-06-06 2023-06-02 B Purchase
2.3
STEINMAN LAWRENCE
Non-Executive Director
30,000 +2.3%
0.43
US$12,930 		30,000 +2.3% 0.43 US$12,930
2022-10-19 2022-10-17 B Purchase
0.5
Delaney David

Member of 10% owner group
1,000 +0.4%
1.11
US$1,110 		1,000 +0.4% 1.11 US$1,110
2022-09-06 2022-09-06 B Purchase
1.8
Shahinian Eric

Member of 10% owner group
21,748 +1.3%
1.13
US$24,632 		21,748 +1.3% 1.13 US$24,632
2022-09-06 2022-09-02 B Purchase
1.8
Shahinian Eric

Member of 10% owner group
11,507 +0.7%
1.14
US$13,105 		11,507 +0.7% 1.14 US$13,105
2022-09-06 2022-09-01 B Purchase
1.8
Shahinian Eric

Member of 10% owner group
55,646 +3.4%
1.13
US$62,630 		55,646 +3.4% 1.13 US$62,630
2022-08-31 2022-08-30 B Purchase
1.8
Shahinian Eric

Member of 10% owner group
17,828 +1.1%
1.15
US$20,452 		17,828 +1.1% 1.15 US$20,452
2022-08-31 2022-08-29 B Purchase
1.8
Shahinian Eric

Member of 10% owner group
5,000 +0.3%
1.17
US$5,840 		5,000 +0.3% 1.17 US$5,840
2022-08-26 2022-08-19 B Purchase
0.7
Geller Avi

Member of 10% owner group
54,644 +inf%
1.30
US$70,939 		54,644 +inf% 1.30 US$70,939
2022-08-18 2022-08-17 B Purchase
1.8
Shahinian Eric
155,773 +10.7%
1.21
US$188,283 		155,773 +10.7% 1.21 US$188,283
Explore more

More insider trading research around Pasithea Therapeutics Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America